能量摄入时机与非酒精性脂肪性肝病中间歇性禁食和时间限制性进食的治疗潜力
本文综述观察性和流行病学数据,描述进食模式与代谢疾病的关联,包括不规律进餐、不吃早餐和夜间进食对肝脏健康的不良影响。作者建议在非酒精性脂肪性肝病(NAFLD)患者风险分层和管理中更多考虑这些行为,并综述间歇性禁食和时间限制性进食在代谢疾病中的人体试验,展望其对NAFLD和非酒精性脂肪性肝炎患者的潜在获益。
要点
- 不规律进餐、不吃早餐和夜间进食与肝脏健康不良影响相关。
- 作者建议在NAFLD风险分层和管理中更多考虑进食时机行为。
- 综述间歇性禁食和时间限制性进食在代谢疾病中的人体试验并展望NAFLD应用。
核心结论
- 作者建议在NAFLD患者风险分层和管理中更多考虑不规律进餐、不吃早餐和夜间进食等有害行为。
- 间歇性禁食和时间限制性进食可能通过恢复自然昼夜节律改善代谢健康,或使NAFLD和非酒精性脂肪性肝炎患者获益。
研究设计与样本
- 综述:总结观察性和流行病学数据、斋月相关研究、临床前和人体初步研究以及间歇性禁食和时间限制性进食在代谢疾病中的人体试验。
主要发现
- 不规律进餐、不吃早餐和夜间进食对肝脏健康有不良影响。
- 在食物持续可及、高达20%人群从事轮班工作且进食时间不规律的24小时社会中,这些有害行为值得更多考虑。
- 斋月为探索禁食的生理影响提供了独特的现实世界机会。
- 临床前和人体初步研究数据为通过调整能量摄入时机改善代谢健康提供了生物学依据,可能通过恢复自然昼夜节律介导。
临床怎么用
- 作者建议在NAFLD患者风险分层和管理中更多考虑不规律进餐、不吃早餐和夜间进食等行为,尤其在24小时社会中。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Non-alcoholic fatty liver disease (NAFLD) represents a major public health concern and is associated with a substantial global burden of liver-related and cardiovascular-related morbidity and mortality. High total energy intake coupled with unhealthy consumption of ultra-processed foods and saturated fats have long been regarded as major dietary drivers of NAFLD. However, there is an accumulating body of evidence demonstrating that the timing of energy intake across a the day is also an important determinant of individual risk for NAFLD and associated metabolic conditions. This review summarises the available observational and epidemiological data describing associations between eating patterns and metabolic disease, including the negative effects of irregular meal patterns, skipping breakfast and night-time eating on liver health. We suggest that that these harmful behaviours deserve greater consideration in the risk stratification and management of patients with NAFLD particularly in a 24-hour society with continuous availability of food and with up to 20% of the population now engaged in shiftwork with mistimed eating patterns. We also draw on studies reporting the liver-specific impact of Ramadan, which represents a unique real-world opportunity to explore the physiological impact of fasting. By highlighting data from preclinical and pilot human studies, we present a further biological rationale for manipulating timing of energy intake to improve metabolic health and discuss how this may be mediated through restoration of natural circadian rhythms. Lastly, we comprehensively review the landscape of human trials of intermittent fasting and time-restricted eating in metabolic disease and offer a look to the future about how these dietary strategies may benefit patients with NAFLD and non-alcoholic steatohepatitis.
引用
- Marjot T, Tomlinson JW, Hodson L, et al. Timing of energy intake and the therapeutic potential of intermittent fasting and time-restricted eating in NAFLD. Gut. 2023. PMID: 37286229. doi:10.1136/gutjnl-2023-329998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。